A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance project.
Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA, USA.
Steven R
SR
Lentz
Hematology, Indiana Hemophilia and Thrombosis Center, Indianapolis, IN, USA.
Anand
A
Tandra
Clinical, Medical, and Regulatory Affairs, Novo Nordisk, Inc, Princeton, NJ, USA.
Robert Z
RZ
Gut
Clinical, Medical, and Regulatory Affairs, Novo Nordisk, Inc, Princeton, NJ, USA.
David L
DL
Cooper